ATEC focuses on new applications of multifunctional thin film. Our two core technologies, 1) High-throughput simulation model optical thin film structure design with customized optoelectronic properties, and 2) Advanced thin film deposition technology for the production of customized optical, mechanical, electronic and isolation films performance films, enabling us to provide high performance films for a wide range of applications. These applications include energy-efficient windows, optical films for building-integrated photovoltaics (BIPV), vehicle-integrated photovoltaics (VIPV), near-infrared transmissive conductive films for automotive sensors, flexible optoelectronic devices (such as flexible solar cells, flexible OLEDs, and LED) encapsulation/transparent electrode film.

For the market pain points, flexible devices have poor barrier properties to H2O and O2 and high encapsulation costs. Also, some customers have specific requirements for optical films, but they face problems such as high development cost and product price. ATEC’s high-throughput simulation of multifunctional film can directly calculate the required materials and the most simplified combination according to customer requirements, which can minimize the cost and development time. Customers can also adjust the proprietary characteristics of the product from many aspects, such as light transmittance, conductivity, appearance, etc, which is unique in the market.

Memdes Bioworks Limited’s original MEMDDS™ complex drug research and development platform uses a combination of new materials and pharmaceutical engineering to prepare sustained-release microspheres, abandoning the traditional homogeneous preparation of sustained-release microspheres. Select appropriate new materials according to the drug system to prepare sustained-release microspheres, and precisely control the drug release time of sustained-release microspheres.

At the same time, Memdes Bioworks Limited is a medical and engineering research and development team composed of pharmaceuticals, pharmacology, new materials, chemicals, medical equipment and other interdisciplinary disciplines, forming equipment and processes with fully independent intellectual property rights, and getting rid of the technology monopoly of foreign companies. Get rid of the monopoly of foreign technology, drug system, preparation equipment, and materials to achieve domestic research and development with independent intellectual property rights. Memdes’s slow-release microspheres have entered the kilogram-level pilot test stage.

The platform is chaired by Associate Professor Wenwei Zhong, a graduate of the University of New South Wales, Australia. The core members include a number of young researchers with chemical engineering and pharmacy backgrounds from renowned universities at home and abroad. The platform utilises self-developed membrane dispersion materials and devices for the preparation of slow-release microspheres, and is actively developing relevant intellectual property rights, with patents and industry standards already in place.

Dai3mimi uses the latest patented acoustic technology of material conduction system from a combined metal & plastic materials to transmit sound waves from the device into the inner ear through the skull directly, making hearing possible by bypassing the outer ear, the eardrum, and the middle ear where these areas are the most easily infected, damaged, and degenerated areas. This Neuro-hearing Technology achieves much clearer sound reception and helps hearing impaired users to hear effortlessly.

Dai3mimi not only restores the hearing ability of the elderly but also provides mobile communication which enables telemedicine for hearing impaired patients. It also helps relieve symptoms such as tinnitus, depression, and dementia through its patented rhythm vibration mechanism.

Sambo is a technology-enabled company that contributes to global carbon neutrality by researching into technologies that save energy, save water and reduce manual cleaning costs. Energy-saving, thermal insulation and self-cleaning nano coating is one of their projects, which is a kind of energy-saving glass coating to reduce building energy consumption and carbon emissions. Through the application of novel material technology, process technology and equipment, we can improve the heat transfer and optical characteristics of glass windows, so as to improve the overall energy efficiency and comfort of the building.

The global construction market is growing rapidly, most of which are commercial and residential buildings. However, the energy consumption of buildings accounts for more than one-third of the world’s total energy consumption, and it is increasing. Therefore, reducing the energy consumption and carbon emissions of buildings has become one of the main goals of global energy conservation and emission reduction. Glass is one of the most common exterior wall materials in buildings, with its heat transfer and optical characteristics. It directly affects the energy efficiency and comfort of the building. Therefore, energy-saving glass coating is very necessary.

It has excellent thermal insulation and optical properties, which can prevent the transfer of heat while maintaining the transparency and refractive index of the glass. Tested by third-party organisations and proven to save homeowners up to 30% on their electricity bills.

Currently, there are many shortcomings in disease detection methods, which often require invasive procedures, can be lengthy and expensive, and may discourage or delay individuals from undergoing testing, resulting in late detection of health issues that may be too advanced to treat effectively. In light of this, Qi Diagnostics aims to utilize a simple and convenient breath test to make testing more accessible and encourage proactive health monitoring, with the goal of achieving earlier diagnosis and treatment of health issues. We expertise in the development and manufacturing of proprietary Volatile Organic Compound (VOC) nano sensor-based in vitro diagnostic and screening devices. The patented sensor technologies have high specificity properties to single targeted gas, which makes it clinical level for detecting specific biomarkers.

Qi Diagnostics’ flagship project is the development of a non-invasive breath test instrument for detecting lung cancer. Compared to traditional lung CT and X-ray examinations, using breath testing methods can provide real-time testing with zero radiation exposure and low cost, making it more accessible to the general public and enabling earlier detection and treatment, thereby increasing the chances of successful recovery. The company aims to expand clinical trials within the next 2 years, with the goal of obtaining clinical certification for the lung cancer breath test instrument and making it available for use by healthcare institutions as soon as possible.